| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |